CAAS Capital Management’s Climb Bio, Inc. Common Stock CLYM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q1
Sell
-75,000
Closed -$785K 644
2021
Q4
$785K Hold
75,000
0.02% 182
2021
Q3
$1.35M Buy
+75,000
New +$1.35M 0.03% 182